An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report
Tóm tắt
Guillain-Barré syndrome is an acquired polyradiculo-neuropathy, often preceded by an antecedent event. It is a monophasic disease but a recurrence rate of 1–6 % is documented in a subset group of patients. Patients with Guillain-Barré syndrome show cerebrospinal fluid albuminocytologic dissociation. Normal cerebrospinal fluid protein levels during both initial and recurrent episodes of Guillain-Barré syndrome is a rare occurrence and has not been described earlier in the literature. Twenty-five-year-old Sri Lankan female with past history of complete recovery following an acute inflammatory demyelinating polyneuropathy (AIDP) variant of Guillain-Barré syndrome 12 years back presented with acute, ascending symmetrical flaccid quadriparasis extending to bulbar muscles, bilateral VII cranial nerves and respiratory compromise needing mechanical ventilation. Nerve conduction study revealed AIDP variant of Guillain-Barré syndrome. Cerebrospinal fluid analysis done after 2 weeks were normal during both episodes without albuminocytologic dissociation. She was treated with intravenous immunoglobulin resulting in a remarkable recovery. Both episodes had a complete clinical recovery in three and four months’ time respectively, rather a faster recovery than usually expected. Recurrence of Guillain-Barré syndrome can occur in a subset of patients with Guillain-Barré syndrome even after many years of asymptomatic period. Normal cerebrospinal fluid profile does not exclude Guillain-Barré syndrome and may occur in subsequent recurrences of Guillain-Barré syndrome arising the need for further studies to identify the pathophysiology and the possibility of a different subtype of Guillain-Barré syndrome.
Tài liệu tham khảo
Winer JB, Hughes RAC, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy. II Antecedent events. J Neurol Neurosurg Psychiatry. 1988;51:613–8.
Seneviratne U. Guillain-Barré syndrome. Postgrad Med J. 2000;76:774–82.
Kuitwaard K, Koningsveld RV, Ruts L, Jacobs BC, Doorn PAV. Recurrent Guillain–Barre ́ syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–9.
Grand'Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent guillain-barre syndrome. Clinical and laboratory features. Brain. 1992;115(4):1093–106.
Das A, Kalita J, Misra UK. Recurrent Guillain Barré syndrome. Electromyogr Clin Neurophysiol. 2004;44(2):95–102.
Hadden RDM. Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP. J Neurol Neurosurg Psychiatry. 2009;80(1):3.
Acute immune polyneuropathies: Neuromuscular. Washington University, 10 Mar 2016. http://neuromuscular.wustl.edu/antibody/gbs.htm. Accessed 20 Mar 2016.
Sharma M, Kes P, et al. Guillain-Barré syndrome in a patient suffering acute myocardial infarction. Acta clin Croat. 2002;41(3):255–7.
Andary M, et al. Guillain-Barré syndrome: Medscape, 2016. http://emedicine.medscape.com/article/315632-overview#a0156. Accessed 02 Mar 2016.
Thivakaran T, Gamage R, Gooneratne IK. Treatment-related fluctuation in Guillain-Barre syndrome. J Neurosci Rural Practice. 2011;2(2):168–70.
Kharbanda PS, Prabhakar S, Lal V, Das CP. Visual loss with papilledema in Guillain-Barre syndrome. Neurol India. 2002;50:528.
Gonzalez-Quevedo A, Carriera RF, O'Farrill ZL, Luis IS, Becquer RM, Luis Gonzalez RS. An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barré syndrome. Neurol India. 2009;57:288–94.
Corston RN, McGale EH, Stonier C, et al. Abnormalities of cerebrospinal fluid amino acids in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1981;44:86–9.